Skip to content
Screener

CapEx at other companies

Pfizer logo
PfizerPFE
$436M-22.7%
Amgen logo
AmgenAMGN
$513M+39.0%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$63K
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$62K
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$2.13M-84.0%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$26K-87.9%

Other financials

Income statement

See full
Revenue$4.6M-90.6%
Operating income-$42.2M-6,158%
Net income-$45.0M-2,043%
EPS (diluted)-$0.62-2,167%

Balance sheet

See full
Cash & equivalents$179.4M+82.6%
Total debt$16.0M-14.3%
Total equity$80.4M-76.0%
Total assets$397.0M-2.8%

Cash flow

See full
Operating cash flow-$31.9M-365%
Free cash flow-$31.9M-376%

Valuation

See full
Market cap$1.7B+83.2%
Enterprise value$1.54B+81.1%
P/S45.8×+38.3×

Profitability

See full
Operating margin-419%-518pp
Net margin-404%-489pp
FCF margin-324.7%-366pp

Returns & leverage

See full
Return on equity-72.3%-117pp
Debt / equity0.2×+0.1×
Current ratio6.3×-1.4×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The source filing: Zymeworks’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001937653-26-000034
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Cash flows from investing activities:
Purchases of marketable securities(34,032)
Proceeds from marketable securities70,17546,552
Acquisition of property and equipment(216)(16)
Acquisition of intangible assets(322)
Net cash provided by investing activities69,95912,182
Cash flows from financing activities:
Issuance of common stock on exercise of stock options8,717772

Item 1. Financial Statements

FAQ

What is Zymeworks's capex?
Zymeworks (ZYME) reported capex of $216K in Q1 2026.
How has Zymeworks's capex changed year-over-year?
Zymeworks's capex increased by 1250.0% year-over-year, from $16K to $216K.
What is the long-term trend for Zymeworks's capex?
Over 3 years (2022 to 2025), Zymeworks's capex has grown at a -42.9% compound annual growth rate (CAGR), from $8.15M to $1.52M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Ask your AI about Zymeworks's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude